The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail

Clavucill 200mg/50mg, tablets for dogs

200, 50 mg/tablet Tablet

V.M.D. n.v/s.a.VPA10817/002/002

Main Information

Trade NameClavucill 200mg/50mg, tablets for dogs
Active SubstancesAmoxicillin
Clavulanic acid
Strength200, 50 mg/tablet
Dosage FormTablet
Licence HolderV.M.D. n.v/s.a.
Licence NumberVPA10817/002/002

Group Information

ATC CodeQJ01CR02 amoxicillin and enzyme inhibitor
Therapeutic ClassAntibiotics


Licence Issued22/05/2015
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version
« Back